Vanderbilt Amyloid Multidisciplinary Program Archive — Page 1 of 1

Charlotte Haffner, a former VUMC patient treated for primary AL amyloidosis, with Franklin Mayor Ken Moore, left, and Muhamed Baljevic, MD.
April 7, 2022

Patient’s amyloidosis awareness efforts recognized

Charlotte Haffner, who was Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat primary AL amyloidosis, was recently recognized by Williamson County Mayor Rogers Anderson and Franklin Mayor Ken Moore.

Five adults gather around a table as a man signs two documents, with the other four standing behind him in a formal interior.
April 5, 2018

Patient’s efforts help shine light on plasma cell disorder

Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease.

A small support group meets around tables in a conference room. A woman in the foreground gestures while speaking, with several attendees seated behind her and papers, notebooks, and water bottles on the tables.
December 6, 2012

Multidisciplinary team takes on rare plasma cell disorder

The Vanderbilt Amyloid Multidisciplinary Program (VAMP) is a new approach to treating a rare and misunderstood disease that can kill its victims before they understand what they have been diagnosed with.